Synthetic opioid drug
Pharmaceutical compound
Betacetylmethadol is a synthetic opioid.[2] It is a diastereoisomer of alphacetylmethadol (as well as levacetylmethadol).[2] In the United States, betacetylmethadol is a Schedule I drug Narcotic under the Controlled Substances Act,[3] with an ACSCN of 9607 and a 2 gramme manufacturing quota as of 2014.[citation needed]
See also
References
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ a b Newman JL, Vann RE, May EL, Beardsley PM (October 2002). "Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats". Psychopharmacology. 164 (1): 108–14. doi:10.1007/s00213-002-1198-8. PMID 12373424. S2CID 19815273.
- ^ 21 U.S.C. § 812(b)(1)
μ-opioid (MOR) |
| ||||
---|---|---|---|---|---|
δ-opioid (DOR) |
| ||||
κ-opioid (KOR) |
| ||||
Nociceptin (NOP) |
| ||||
Others |
|